Caxton Associates (New York)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17,312
| Closed | -$587K | – | 582 |
|
|
2022
Q4 | $587K | Buy |
17,312
+13,943
| +414% | +$473K | 0.04% | 192 |
|
|
2022
Q3 | $162K | Sell |
3,369
-4,225
| -56% | -$203K | 0.02% | 406 |
|
|
2022
Q2 | $433K | Buy |
+7,594
| New | +$433K | 0.04% | 294 |
|
|
2019
Q4 | – | Sell |
-673
| Closed | -$184K | – | 499 |
|
|
2019
Q3 | $184K | Buy |
+673
| New | +$184K | 0.04% | 345 |
|